Di Domenico, F. ., Sultana, R. ., Barone, E. ., Perluigi, M. ., Cini, C. ., Mancuso, C. ., … Butterfield, D. . (2011). Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer’s disease subjects. Journal of Proteomics, 74(7), 1091-103. https://doi.org/10.1016/j.jprot.2011.03.033 (Original work published 2011)

Barone, E. ., Di Domenico, F. ., Cenini, G. ., Sultana, R. ., Coccia, R. ., Preziosi, P. ., … Butterfield, D. . Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer’s disease and amnestic mild cognitive impairment. Journal of Alzheimer’s Disease : JAD, 25(4), 623-33. https://doi.org/10.3233/JAD-2011-110092 (Original work published 2011)

Perluigi, M. ., Di Domenico, F. ., Fiorini, A. ., Cocciolo, A. ., Giorgi, A. ., Foppoli, C. ., … Coccia, R. . (1969). (no title).

Barone, E. ., Di Domenico, F. ., Cenini, G. ., Sultana, R. ., Cini, C. ., Preziosi, P. ., … Butterfield, D. . (2011). Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment. Biochimica Et Biophysica Acta, 1812(4), 480-7. https://doi.org/10.1016/j.bbadis.2011.01.005

Barone, E. ., Cenini, G. ., Di Domenico, F. ., Martin, S. ., Sultana, R. ., Mancuso, C. ., … Butterfield, D. . (2011). Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action. Pharmacological Research, 63(3), 172-80. https://doi.org/10.1016/j.phrs.2010.12.007

Di Domenico, F. ., Perluigi, M. ., Butterfield, D. ., Cornelius, C. ., & . (2010). Oxidative damage in rat brain during aging: interplay between energy and metabolic key target proteins. Neurochemical Research, 35(12), 2184-92. https://doi.org/10.1007/s11064-010-0295-z (Original work published 2010)

Sultana, R. ., Di Domenico, F. ., Tseng, M. ., Cai, J. ., Noel, T. ., Chelvarajan, R. ., … Butterfield, D. . (2010). Doxorubicin-induced thymus senescence. Journal of Proteome Research, 9(12), 6232-41. https://doi.org/10.1021/pr100465m (Original work published 2010)

Lanzillotta, C. ., Di Domenico, F. ., Perluigi, M. ., & Butterfield, D. . (2019). Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives. CNS Drugs, 33(10), 957-969. https://doi.org/10.1007/s40263-019-00658-8

Di Domenico, F. ., Tramutola, A. ., Barone, E. ., Lanzillotta, C. ., Defever, O. ., Arena, A. ., … Perluigi, M. . (2019). Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome. Redox Biology, 23, 101162. https://doi.org/10.1016/j.redox.2019.101162

Sharma, N. ., Tramutola, A. ., Lanzillotta, C. ., Arena, A. ., Blarzino, C. ., Cassano, T. ., … Barone, E. . (2019). Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer’s disease. Neurobiology of Disease, 125, 176-189. https://doi.org/10.1016/j.nbd.2019.02.003